A quarter of people seeking care for symptoms of chronic respiratory diseases in Kenya may incur "catastrophic" health costs, ...

Digital inhalers may help predict impending acute exacerbations of chronic obstructive pulmonary disease (COPD), according to ...

Yoga can be a valuable complement to pulmonary therapy for chronic respiratory diseases, such as COPD and asthma. By ...

Prevalence of chronic obstructive pulmonary disease (COPD) and the disease's burden varies significantly by state.

Researchers discover an unusual accumulation of particles in people with the disease; the causes are still unclear.

All diseases exist on a continuum, and the damage often begins early—sometimes as soon as a child is weaned off breast milk ...

Regardless of chronic obstructive pulmonary disease status, finerenone mitigates clinical events and symptoms in patients with HFmrEF or HFpEF.

In 2023, tuberculosis claimed approximately 1·3 million lives,1 providing a stark reminder of the persistent inequities and ...

Chronic obstructive pulmonary disease (COPD) affects 25 million people in the U.S. and is the fifth leading cause of death ...

Shyamali Dharmage grew up in rural Sri Lanka and was inspired to become a doctor after watching the impact of the local ...

Theravance Biopharma’s partner Viatris has received China's NMPA approval for Yupelri inhalation solution for maintenance treatment of COPD.

Quantitative CT textures may provide imaging evidence of the spatial heterogeneity of lung inflammation and disease burden in COPD.